Organization
Indiana Hemophilia & Thrombosis Center
3 clinical trials
Clinical trial
Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient PopulationStatus: Active (not recruiting), Estimated PCD: 2027-10-01
Clinical trial
Prospective, Single-arm, Open-label Use of Hemlibra (Emicizumab) to Treat Hemophilic PseudotumorStatus: Terminated, Estimated PCD: 2022-03-16
Clinical trial
Prospective, Single-Arm, Open-Label Use of Hemlibra (Emicizumab) in the Treatment of Mild Hemophilia AStatus: Recruiting, Estimated PCD: 2025-07-01